Cancer Biopsies Market Growth, Demand & Size by 2034

Cancer Biopsies Market Size and Forecasts (2021–2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Product (Instrument, Kits and Consumables, Services); Type (Tissue Biopsy, Surgical Biopsy, Liquid Biopsy, Other Types); Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Other Applications); End User (Hospitals, Diagnostics Laboratories, Other End Users); and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024   |   Base Year: 2025   |   Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00040619
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
Buy Now
Cancer Biopsies Market Growth, Demand & Size by 2034
Report Date: Jul 2026   |   Report Code: TIPRE00040619 Email: sales@theinsightpartners.com
Buy Now

The Cancer Biopsies Market size is expected to reach US$ 66.41 Billion by 2034 from US$ 32.68 Billion in 2025. The market is estimated to record a CAGR of 9.27% from 2026 to 2034.

The report is segmented by Product (Instrument, Kits and Consumables, and Services). The report further presents analysis based on the Type (Tissue Biopsy, Surgical Biopsy, Liquid Biopsy, and Other Types), Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, and Other Applications), End User (Hospitals, Diagnostics Laboratories, and Other End Users). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Cancer Biopsies Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Cancer Biopsies Market Segmentation Product

  1. Instrument
  2. Kits and Consumables
  3. Services

Type

  1. Tissue Biopsy
  2. Surgical Biopsy
  3. Liquid Biopsy
  4. Other Types

Application

  1. Breast Cancer
  2. Colorectal Cancer
  3. Cervical Cancers
  4. Lung Cancers
  5. Other Applications

End User

  1. Hospitals
  2. Diagnostics Laboratories
  3. Other End Users

Market Research Highlights

  • Global market for Cancer Biopsies was valued at US$ 32.68 Billion in 2025
  • Annual market size is expected to reach US$ 66.41 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 470.27 Billion
  • Market is anticipated to register a CAGR of 9.27% during the forecast period
  • The United States represents a key market, supported by Growing Cancer Incidence, Advancements in Biopsy Techniques, Increased Focus on Early Cancer Detection, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expanding Liquid Biopsy Applications, Growth in Personalized Medicine, Emerging Markets Adoption are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Roche, Thermo Fisher Scientific, Hologic, Siemens Healthineers, Becton Dickinson, Medtronic, Johnson & Johnson, GE Healthcare, Exact SciencesAgilent Technologies, Illumina, Labcorp, while analyzing competitive strategies and innovation developments

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Cancer Biopsies Market: Strategic Insights

cancer-biopsies-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Cancer Biopsies Market Growth Drivers

  1. Growing Cancer Incidence: The increasing global prevalence of cancer is a major driver for the cancer biopsies market. As early diagnosis and precise cancer staging are critical for successful treatment, the demand for accurate and efficient biopsy methods is on the rise, particularly for lung, breast, and colorectal cancers.
  2. Advancements in Biopsy Techniques: Innovations in biopsy techniques, including liquid biopsies, molecular diagnostics, and minimally invasive procedures, are revolutionizing cancer diagnosis. These advancements allow for faster, more precise, and less invasive cancer detection, driving the demand for cutting-edge biopsy solutions.
  3. Increased Focus on Early Cancer Detection: The healthcare industry's growing emphasis on early cancer detection, which improves treatment outcomes, is spurring the adoption of biopsies. Early detection methods, like biopsy and imaging, allow for more personalized and targeted treatments, which improve patient survival rates and reduce overall healthcare costs.

Cancer Biopsies Market Future Trends

  1. Adoption of Liquid Biopsy: Liquid biopsy is a rapidly growing trend due to its non-invasive nature. Liquid biopsy tests, such as blood tests for circulating tumor DNA, offer a promising alternative to traditional tissue biopsies for detecting genetic mutations, recurrence, and metastasis, thereby enhancing personalized treatment plans.
  2. Integration of Artificial Intelligence (AI): AI is increasingly integrated into cancer biopsy analysis. AI algorithms can assist pathologists in accurately interpreting biopsy samples, identifying cancerous cells more effectively, and enhancing diagnostic precision. This integration supports better decision-making in cancer treatment and improves patient outcomes.
  3. Minimally Invasive Biopsy Techniques: Minimally invasive biopsy techniques, such as fine needle aspiration (FNA) and core needle biopsies, are trending due to their lower complication rates and quicker recovery times compared to traditional surgical biopsies. These techniques are becoming the preferred choice for both patients and healthcare providers.

Cancer Biopsies Market Opportunities

  1. Expanding Liquid Biopsy Applications: Liquid biopsy’s ability to detect a wide range of cancers through blood samples presents an opportunity to expand its applications. As research progresses, liquid biopsy could become the standard for early cancer detection, providing vast market potential for companies developing these tests.
  2. Growth in Personalized Medicine: The rise of personalized medicine, driven by genomic profiling and targeted therapies, presents an opportunity for the cancer biopsy market. Biopsies help identify genetic mutations and biomarkers, enabling more targeted treatments that improve outcomes and reduce adverse effects.
  3. Emerging Markets Adoption: Emerging markets, particularly in Asia-Pacific and Latin America, present untapped opportunities for cancer biopsy manufacturers. With increasing cancer incidence and rising healthcare investment, these regions offer a growing demand for affordable, accessible diagnostic tools and technologies.

Cancer Biopsies Market Report Scope

Report Attribute Details
Market size in 2025 US$ 32.68 Billion
Market Size by 2034 US$ 66.41 Billion
Global CAGR (2026 - 2034) 9.27%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product
  • Instrument
  • Kits and Consumables
  • Services
By Type
  • Tissue Biopsy
  • Surgical Biopsy
  • Liquid Biopsy
  • Other Types
By Application
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Other Applications
By End User
  • Hospitals
  • Diagnostics Laboratories
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Roche
  • Thermo Fisher Scientific
  • Hologic
  • Siemens Healthineers
  • Becton Dickinson
  • Medtronic
  • Johnson & Johnson
  • GE Healthcare
  • Exact SciencesAgilent Technologies
  • Illumina
  • Labcorp

Cancer Biopsies Market Players Density: Understanding Its Impact on Business Dynamics

The Cancer Biopsies Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

cancer-biopsies-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Cancer Biopsies Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Cancer Biopsies Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The rising cancer incidence, advancements in biopsy techniques, and the increasing emphasis on early cancer detection are the primary drivers.

Liquid biopsy is offering a less invasive alternative to traditional tissue biopsies, enabling early detection and improved cancer monitoring.

AI is enhancing biopsy analysis, improving diagnostic accuracy, and aiding pathologists in identifying cancerous cells for better patient outcomes

High costs, regulatory hurdles, and the need for widespread clinical validation of new biopsy techniques are major challenges.

North America leads the market, but significant growth is expected in emerging markets in Asia-Pacific and Latin America due to rising cancer rates.

Expanding liquid biopsy applications, leveraging AI in diagnostics, and targeting emerging markets offer substantial growth opportunities.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: May 2026